Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Robert P. Smith, Klaus-Peter Hunfeld & Peter J Krause. (2020) Management strategies for human babesiosis. Expert Review of Anti-infective Therapy 18:7, pages 625-636.
Read now
Read now
Timothy R Pasquale & James S Tan. (2005) Update on antimicrobial agents: new indications of older agents. Expert Opinion on Pharmacotherapy 6:10, pages 1681-1691.
Read now
Read now
. (2004) Evidence-based guidelines for the management of Lyme disease. Expert Review of Anti-infective Therapy 2:sup1, pages S1-S13.
Read now
Read now
Ryland P Byrd Jr & Thomas M Roy. (2002) Acute respiratory distress syndrome following treatment for babesiosis. Expert Opinion on Pharmacotherapy 3:11, pages 1541-1542.
Read now
Read now
Articles from other publishers (40)
Richard I. Horowitz, John Fallon & Phyllis R. Freeman. (2023) Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections. Microorganisms 11:9, pages 2301.
Crossref
Crossref
Lluís Valerio Sallent, Laura Soldevila Langa, Silvia Roure Díez, Andrés Martínez Arias & Xavier Vallès Casanova. (2022) Enfermedades transmitidas por picadura de garrapatas. FMC - Formación Médica Continuada en Atención Primaria 29:8, pages 422-429.
Crossref
Crossref
Daniel Sojka, Marie Jalovecká & Jan Perner. (2022) Babesia, Theileria, Plasmodium and Hemoglobin. Microorganisms 10:8, pages 1651.
Crossref
Crossref
Martina Karasová, Csilla Tóthová, Simona Grelová & Mária Fialkovičová. (2022) The Etiology, Incidence, Pathogenesis, Diagnostics, and Treatment of Canine Babesiosis Caused by Babesia gibsoni Infection. Animals 12:6, pages 739.
Crossref
Crossref
Emmanuel Cigan, Bettina Eggbauer, Joerg H. Schrittwieser & Wolfgang Kroutil. (2021) The role of biocatalysis in the asymmetric synthesis of alkaloids – an update. RSC Advances 11:45, pages 28223-28270.
Crossref
Crossref
Amani Magdy Beshbishy, Gaber El-Saber Batiha, Naoaki Yokoyama & Ikuo Igarashi. (2019) Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo. Parasites & Vectors 12:1.
Crossref
Crossref
Gaber El-Saber Batiha, Amany Magdy Beshbishy, Dickson Stuart Tayebwa, Hazem Mohammed Shaheen, Naoaki Yokoyama & Ikuo Igarashi. (2019) Inhibitory effects of Syzygium aromaticum and Camellia sinensis methanolic extracts on the growth of Babesia and Theileria parasites. Ticks and Tick-borne Diseases 10:5, pages 949-958.
Crossref
Crossref
Gaber El-Saber Batiha, Amany Magdy Beshbishy, Dickson Stuart Tayebwa, Oluyomi Stephen Adeyemi, Hazem Shaheen, Naoaki Yokoyama & Ikuo Igarashi. (2019) The effects of trans-chalcone and chalcone 4 hydrate on the growth of Babesia and Theileria. PLOS Neglected Tropical Diseases 13:5, pages e0007030.
Crossref
Crossref
Zetian Chen, Huiqin Li, Xiaoge Gao, Anning Bian, Hongru Yan, Delong Kong & Xiangye Liu. (2019) Human Babesiosis in China: a systematic review. Parasitology Research 118:4, pages 1103-1112.
Crossref
Crossref
Arsalan Alvi, Sonali Gupta, Pradeep Goyal, Jose Pichardo & Joseph Mattana. (2019) Splenic infarction as a rare presentation of severe babesiosis. IDCases 15, pages e00491.
Crossref
Crossref
Kristina N. Feja. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1298
1303.e2
.
Alaina K. Pyle. 2018. Neonatal Infections. Neonatal Infections
173
180
.
Tamer Akel & Neville Mobarakai. (2017) Hematologic manifestations of babesiosis. Annals of Clinical Microbiology and Antimicrobials 16:1.
Crossref
Crossref
Ketsarin Kamyingkird, Shinuo Cao, Bumduuren Tuvshintulga, Akram Salama, Ahmed Abdelmoniem Mousa, Artemis Efstratiou, Yoshifumi Nishikawa, Naoaki Yokoyama, Ikuo Igarashi & Xuenan Xuan. (2017) Effects of dihydroorotate dehydrogenase (DHODH) inhibitors on the growth of Theileria equi and Babesia caballi in vitro. Experimental Parasitology 176, pages 59-65.
Crossref
Crossref
Esra Tanyel, Nil Guler, Murat Hokelek, Fatma Ulger & Mustafa Sunbul. (2015) A case of severe babesiosis treated successfully with exchange transfusion. International Journal of Infectious Diseases 38, pages 83-85.
Crossref
Crossref
James S. McCarthy & Richard N. Price. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
495
509.e5
.
Elodie Poisnel, Mikael Ebbo, Yael Berda-Haddad, Benoit Faucher, Emmanuelle Bernit, Bernard Carcy, Renaud Piarroux, Jean-Robert Harlé & Nicolas Schleinitz. (2013) Babesia microti:an unusual travel-related disease. BMC Infectious Diseases 13:1.
Crossref
Crossref
A. Hildebrandt, J. S. Gray & K.-P. Hunfeld. (2013) Human Babesiosis in Europe: what clinicians need to know. Infection 41:6, pages 1057-1072.
Crossref
Crossref
Aiko Iguchi, Aya Matsuu, Yoshito Fujii, Hiromi Ikadai & Yoshiaki Hikasa. (2013) The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs. Veterinary Parasitology 197:3-4, pages 527-533.
Crossref
Crossref
Robert W. TolanJrJr. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1261
1265.e2
.
Elizabeth Chiang & Nairmeen Haller. (2011) Babesiosis: An emerging infectious disease that can affect those who travel to the northeastern United States. Travel Medicine and Infectious Disease 9:5, pages 238-242.
Crossref
Crossref
Angela Nehrbass-Stuedli, David Boykin, Richard R. Tidwell & Reto Brun. (2011)
Novel Diamidines with Activity against Babesia divergens
In Vitro
and Babesia microti
In Vivo
. Antimicrobial Agents and Chemotherapy 55:7, pages 3439-3445.
Crossref
Crossref
Mohamad Alaa Terkawi & Ikuo Igarashi. 2011. Apicomplexan Parasites. Apicomplexan Parasites
453
467
.
THOMAS A. MOORE. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
631
668
.
Zbigniew M. Szczepiorkowski, Jeffrey L. Winters, Nicholas Bandarenko, Haewon C. Kim, Michael L. Linenberger, Marisa B. Marques, Ravindra Sarode, Joseph Schwartz, Robert Weinstein & Beth H. Shaz. (2010) Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis. Journal of Clinical Apheresis 25:3, pages 83-177.
Crossref
Crossref
M. Sakuma, A. Setoguchi & Y. Endo. (2009)
Possible Emergence of Drug-Resistant Variants of
Babesia gibsoni
in Clinical Cases Treated with Atovaquone and Azithromycin
. Journal of Veterinary Internal Medicine 23:3, pages 493-498.
Crossref
Crossref
Oliver Liesenfeld. 2009. Lexikon der Infektionskrankheiten des Menschen. Lexikon der Infektionskrankheiten des Menschen
55
56
.
P. Bourée, P. Resende, A. Gagnepain-Lacheteau & E. Marsaudon. (2008) Une protozoose mal connue : la babésiose. Antibiotiques 10:2, pages 61-68.
Crossref
Crossref
Eduardo Ortega-Barria & Elidia Dominguez. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
1228
1231
.
J. M. Vyas, S. R. Telford & G. K. Robbins. (2007) Treatment of Refractory Babesia microti Infection with Atovaquone-Proguanil in an HIV-Infected Patient: Case Report. Clinical Infectious Diseases 45:12, pages 1588-1588.
Crossref
Crossref
Martin Schlitzer. (2007) Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development. ChemMedChem 2:7, pages 944-986.
Crossref
Crossref
Zbigniew M. Szczepiorkowski, Nicholas Bandarenko, Haewon C. Kim, Michael L. Linenberger, Marisa B. Marques, Ravindra Sarode, Joseph Schwartz, Beth H. Shaz, Robert Weinstein, Ashka Wirk & Jeffrey L. Winters. (2007) Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis. Journal of Clinical Apheresis 22:3, pages 106-175.
Crossref
Crossref
Stephen J. Swanson, David Neitzel, Kurt D. Reed & Edward A. Belongia. (2006)
Coinfections Acquired from
Ixodes
Ticks
. Clinical Microbiology Reviews 19:4, pages 708-727.
Crossref
Crossref
Eric Richier, Giancarlo A. Biagini, Sharon Wein, Frederic Boudou, Patrick G. Bray, Steve A. Ward, Eric Precigout, Michèle Calas, Jean-François Dubremetz & Henri J. Vial. (2006)
Potent Antihematozoan Activity of Novel Bisthiazolium Drug T16: Evidence for Inhibition of Phosphatidylcholine Metabolism in Erythrocytes Infected with
Babesia
and
Plasmodium
spp
. Antimicrobial Agents and Chemotherapy 50:10, pages 3381-3388.
Crossref
Crossref
P. Meliani, S. Khatibi, S. Randazzo, A. Gorenflot & B. Marchou. (2006) Babésioses humaines. Médecine et Maladies Infectieuses 36:10, pages 499-504.
Crossref
Crossref
Henri J. Vial & A. Gorenflot. (2006) Chemotherapy against babesiosis. Veterinary Parasitology 138:1-2, pages 147-160.
Crossref
Crossref
Ritchie C. Shoemaker, H. Kenneth Hudnell, Dennis E. House, Amy van Kempen & Gary E. Pakes. (2006) Atovaquone plus cholestyramine in patients coinfected withBabesia microti andBorrelia burgdorferi refractory to other treatment. Advances in Therapy 23:1, pages 1-11.
Crossref
Crossref
Aya Matsuu, Yushi Koshida, Megumi Kawahara, Kenichi Inoue, Hiromi Ikadai, Yoshiaki Hikasa, Shozo Okano & Seiichi Higuchi. (2004) Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro. Veterinary Parasitology 124:1-2, pages 9-18.
Crossref
Crossref
Virginia T. Sherr. (2004) Human babesiosis – an unrecorded reality. Medical Hypotheses 63:4, pages 609-615.
Crossref
Crossref
Timothy J. Egan. (2003) Haemozoin (malaria pigment): a unique crystalline drug target. TARGETS 2:3, pages 115-124.
Crossref
Crossref